Asklepios Klinik Langen

Langen, Germany
General hospital in Langen, Hessen
Röntgenstraße 20, 63225 Langen (Hessen)

About Asklepios Klinik Langen


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
4
Charite University, Berlin, Germany
1
Otto-von-Guericke University Magdeburg
1
Resverlogix Corp
1
University of Leipzig
1
Total Rows: 5

Clinical Trials at Asklepios Klinik Langen


During the past decade, Asklepios Klinik Langen conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years110022000011000000110000Started TrialsCompleted Trails2015201620172018201920200123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Intraaortic Balloon Pump in Cardiogenic Shock II
2009-06-01
2016-10-01
Completed
600
Wedge Resection or Parietal Pleurectomy for the Treatment of Recurrent Pneumothorax (WOPP)
2013-11-01
2024-08-01
Active, not recruiting
360
Telemedical Interventional Management in Heart Failure II
2013-08-08
2018-05-17
Completed
1,571
Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)
2014-07-22
2017-06-05
Completed
2,725
Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD
2015-11-01
2021-06-21
Completed
2,425
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
2017-03-02
2021-04-26
Completed
5,988
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
2017-03-06
2020-05-28
Completed
3,730
A Study to Test the Effect of Empagliflozin in Patients Who Are in Hospital for Acute Heart Failure
2020-05-18
2021-06-02
Completed
530

Rows per page:

1–8 of 8

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Asklepios Klinik Langen" #1 sponsor was "Boehringer Ingelheim" with 4 trials, followed by "Charite University, Berlin, Germany" with 1 trials sponsored, "Otto-von-Guericke University Magdeburg" with 1 trials sponsored, "Resverlogix Corp" with 1 trials sponsored and "University of Leipzig" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Asklepios Klinik Langen" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "German Federal Ministry of Education and Research" with 1 trials as a collaborator, "German Research Foundation" with 1 trials as a collaborator, "ICON plc" with 1 trials as a collaborator and "Medidata Solutions" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.
Created with Highcharts 11.1.0Top Leading SponsorsBoehringer Ingelheim: 4Boehringer Ingelheim: 4Charite University,Berlin, Germany: 1Charite University,Berlin, Germany: 1Otto-von-GuerickeUniversity Magdeburg:1Otto-von-GuerickeUniversity Magdeburg:1Resverlogix Corp: 1Resverlogix Corp: 1University of Leipzig: 1University of Leipzig: 1

Created with Highcharts 11.1.0Top CollaboratorsEli Lilly and Company: 3Eli Lilly and Company: 3German FederalMinistry of Educationand Research: 1German FederalMinistry of Educationand Research: 1German Research Foundation: 1German Research Foundation: 1ICON plc: 1ICON plc: 1Medidata Solutions: 1Medidata Solutions: 1PPD: 1PPD: 1University of Leipzig: 1University of Leipzig: 1

Clinical Trials Conditions at Asklepios Klinik Langen


According to Clinical.Site data, the most researched conditions in "Asklepios Klinik Langen" are "Heart Failure" (3 trials), "Atrial Fibrillation" (1 trials), "Chronic Heart Failure" (1 trials), "Coronary Artery Disease" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Asklepios Klinik Langen" in a lesser frequency.

Clinical Trials Intervention Types at Asklepios Klinik Langen


Most popular intervention types in "Asklepios Klinik Langen" are "Drug" (5 trials), "Device" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Empagliflozin" (3 trials), "Placebo" (3 trials), "Apabetalone" (1 trials), "Aspirin" (1 trials) and "Atorvastatin" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Asklepios Klinik Langen


The vast majority of trials in "Asklepios Klinik Langen" are 8 trials for "All" genders.

Clinical Trials Status at Asklepios Klinik Langen


Currently, there are NaN active trials in "Asklepios Klinik Langen". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Asklepios Klinik Langen, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Asklepios Klinik Langen, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 6Phase 3: 6Not Applicable: 1Not Applicable: 1Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 7Completed: 7Active, not recruiting: 1Active, not recruiting: 1